Literature DB >> 28123641

Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44.

Jun Li1, Juan Wei2, Zhu Mei3, Yongmei Yin1, Yongfei Li1, Mingjie Lu1, Shidai Jin1.   

Abstract

Recent studies show that many microRNAs (miRNAs) are found to play important roles in breast cancer, however, most of miRNAs are not investigated completely. In the present study, significant down-regulation of miR-520a-3p was found in the breast cancer tissues and cell lines. The restoration of miR-520a-3p expression in breast cancer cells could inhibit cell proliferation, migration and invasion. In addition, miR-520a-3p was able to induce breast cancer cell apoptosis. Luciferase assay was used to confirm that CCND1 and CD44 were the direct target genes of miR-520a-3p. The ectopic expression of miR-520a-3p repressed CCND1 and CD44 expression on post-transcriptional levels in breast cancer cells. This study suggests that miR-520a-3p may act as an optional method for breast cancer therapy.

Entities:  

Keywords:  CCND1; CD44; breast cancer; metastasis; miR-520a-3p; proliferation

Year:  2017        PMID: 28123641      PMCID: PMC5250711     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  22 in total

1.  Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.

Authors:  Takatsugu Ishimoto; Hidetaka Sugihara; Masayuki Watanabe; Hiroshi Sawayama; Masaaki Iwatsuki; Yoshifumi Baba; Hirohisa Okabe; Kosei Hidaka; Naomi Yokoyama; Keisuke Miyake; Momoko Yoshikawa; Osamu Nagano; Yoshihiro Komohara; Motohiro Takeya; Hideyuki Saya; Hideo Baba
Journal:  Carcinogenesis       Date:  2013-12-06       Impact factor: 4.944

2.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.

Authors:  Qihong Huang; Kiranmai Gumireddy; Mariette Schrier; Carlos le Sage; Remco Nagel; Suresh Nair; David A Egan; Anping Li; Guanghua Huang; Andres J Klein-Szanto; Phyllis A Gimotty; Dionyssios Katsaros; George Coukos; Lin Zhang; Ellen Puré; Reuven Agami
Journal:  Nat Cell Biol       Date:  2008-01-13       Impact factor: 28.824

3.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

Review 4.  MicroRNAs as potential biomarkers in cancer: opportunities and challenges.

Authors:  Huiyin Lan; Haiqi Lu; Xian Wang; Hongchuan Jin
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

Review 5.  The Roles of MicroRNAs in Breast Cancer.

Authors:  Ryou-U Takahashi; Hiroaki Miyazaki; Takahiro Ochiya
Journal:  Cancers (Basel)       Date:  2015-04-09       Impact factor: 6.639

Review 6.  MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients.

Authors:  M Pichler; G A Calin
Journal:  Br J Cancer       Date:  2015-07-09       Impact factor: 7.640

7.  miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.

Authors:  Bairong Xia; Shanshan Yang; Tianbo Liu; Ge Lou
Journal:  Mol Cancer       Date:  2015-03-11       Impact factor: 27.401

8.  MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression.

Authors:  Chia-Hui Wang; Daniel Y Lee; Zhaoqun Deng; Zina Jeyapalan; Shao-Chen Lee; Shireen Kahai; Wei-Yang Lu; Yaou Zhang; Burton B Yang
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

Review 9.  MicroRNA Processing and Human Cancer.

Authors:  Masahisa Ohtsuka; Hui Ling; Yuichiro Doki; Masaki Mori; George Adrian Calin
Journal:  J Clin Med       Date:  2015-08-21       Impact factor: 4.241

Review 10.  Revealing the Complexity of Breast Cancer by Next Generation Sequencing.

Authors:  John Verigos; Angeliki Magklara
Journal:  Cancers (Basel)       Date:  2015-11-06       Impact factor: 6.639

View more
  22 in total

1.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

2.  MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression.

Authors:  Jingwei Li; Wei Shao; Junhong Zhao
Journal:  Hum Cell       Date:  2020-11-16       Impact factor: 4.174

Review 3.  Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential.

Authors:  Dharambir Kashyap; Hardeep Singh Tuli; Vivek Kumar Garg; Neelam Goel; Anupam Bishayee
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

4.  CCND1 silencing suppresses liver cancer stem cell differentiation through inhibiting autophagy.

Authors:  Hongying Zhang
Journal:  Hum Cell       Date:  2019-10-30       Impact factor: 4.174

5.  Genome-wide miRNA response to anacardic acid in breast cancer cells.

Authors:  David J Schultz; Penn Muluhngwi; Negin Alizadeh-Rad; Madelyn A Green; Eric C Rouchka; Sabine J Waigel; Carolyn M Klinge
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

6.  Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1.

Authors:  Wei Zhao; Jin-Xia Hu; Rui-Min Hao; Qian Zhang; Jun-Qi Guo; You-Jie Li; Ning Xie; Lu-Ying Liu; Ping-Yu Wang; Can Zhang; Shu-Yang Xie
Journal:  Oncol Rep       Date:  2018-07-24       Impact factor: 3.906

7.  LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.

Authors:  Jing Lin; Shasha Liao; Zewa Liu; E Li; Xiaohua Wu; Wanting Zeng
Journal:  Cancer Biol Ther       Date:  2021-04-02       Impact factor: 4.742

8.  Identification of TUBB2A by quantitative proteomic analysis as a novel biomarker for the prediction of distant metastatic breast cancer.

Authors:  Dongyoon Shin; Joonho Park; Dohyun Han; Ji Hye Moon; Han Suk Ryu; Youngsoo Kim
Journal:  Clin Proteomics       Date:  2020-05-24       Impact factor: 3.988

9.  LncRNA SNHG16 Facilitates Nasopharyngeal Carcinoma Progression by Acting as ceRNA to Sponge miR-520a-3p and Upregulate MAPK1 Expression.

Authors:  Qingwei Wu; Yingying Zhao; Runjie Shi; Tao Wang
Journal:  Cancer Manag Res       Date:  2021-05-20       Impact factor: 3.989

10.  Long Non-coding RNA FIRRE Acts as a miR-520a-3p Sponge to Promote Gallbladder Cancer Progression via Mediating YOD1 Expression.

Authors:  Shuqing Wang; Yang Wang; Shouhua Wang; Huanjun Tong; Zhaohui Tang; Jiandong Wang; Yongjie Zhang; Jingmin Ou; Zhiwei Quan
Journal:  Front Genet       Date:  2021-06-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.